WFIKKN1 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: WFIKKN1 (WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1) Homo sapiens
Analyze
Symbol: WFIKKN1
Name: WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
RGD ID: 1342711
HGNC Page HGNC:30912
Description: Enables receptor antagonist activity and transforming growth factor beta binding activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway. Predicted to be located in extracellular region. Predicted to be active in extracellular space.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: C16orf12; chromosome 16 open reading frame 12; GASP-2; growth and differentiation factor-associated serum protein 2; hGASP-2; MGC126651; MGC126655; RJD2; WAP four-disulfide core domain 20A; WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing protein; WAP, FS, Ig, KU, and NTR-containing protein; WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1; WFDC20A; WFIKKN
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh3816630,985 - 634,117 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl16629,239 - 634,117 (+)EnsemblGRCh38hg38GRCh38
GRCh3716680,985 - 684,117 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 3616621,013 - 624,117 (+)NCBINCBI36Build 36hg18NCBI36
Build 3416621,012 - 624,117NCBI
Celera16881,146 - 884,250 (+)NCBICelera
Cytogenetic Map16p13.3NCBI
HuRef16602,311 - 605,379 (+)NCBIHuRef
CHM1_116680,850 - 683,953 (+)NCBICHM1_1
T2T-CHM13v2.016635,019 - 638,150 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
References

References - curated
# Reference Title Reference Citation
1. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
2. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:11157797   PMID:11274388   PMID:11928817   PMID:12477932   PMID:12709070   PMID:15146197   PMID:16791741   PMID:18596030   PMID:21054789   PMID:21873635   PMID:21900206   PMID:23829672  
PMID:27325460   PMID:27782377   PMID:30021884   PMID:32296183   PMID:32393512   PMID:33961781  


Genomics

Comparative Map Data
WFIKKN1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh3816630,985 - 634,117 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl16629,239 - 634,117 (+)EnsemblGRCh38hg38GRCh38
GRCh3716680,985 - 684,117 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 3616621,013 - 624,117 (+)NCBINCBI36Build 36hg18NCBI36
Build 3416621,012 - 624,117NCBI
Celera16881,146 - 884,250 (+)NCBICelera
Cytogenetic Map16p13.3NCBI
HuRef16602,311 - 605,379 (+)NCBIHuRef
CHM1_116680,850 - 683,953 (+)NCBICHM1_1
T2T-CHM13v2.016635,019 - 638,150 (+)NCBIT2T-CHM13v2.0
Wfikkn1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391726,096,602 - 26,099,832 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1726,096,602 - 26,099,832 (-)EnsemblGRCm39 Ensembl
GRCm381725,877,628 - 25,880,858 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1725,877,628 - 25,880,858 (-)EnsemblGRCm38mm10GRCm38
MGSCv371726,014,573 - 26,017,803 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361725,605,228 - 25,608,458 (-)NCBIMGSCv36mm8
Celera1726,410,684 - 26,413,914 (-)NCBICelera
Cytogenetic Map17A3.3NCBI
cM Map1712.97NCBI
Wfikkn1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81015,400,953 - 15,403,280 (-)NCBIGRCr8
mRatBN7.21014,896,442 - 14,898,770 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1014,896,378 - 14,899,863 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1019,635,433 - 19,637,760 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01019,124,311 - 19,126,638 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01014,624,649 - 14,626,973 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01015,243,429 - 15,245,757 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1015,243,429 - 15,245,757 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01015,056,372 - 15,058,700 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41015,141,826 - 15,144,154 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
Celera1014,565,306 - 14,567,634 (-)NCBICelera
Cytogenetic Map10q12NCBI
Wfikkn1
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495544216,569,046 - 16,577,650 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495544216,573,094 - 16,577,650 (-)NCBIChiLan1.0ChiLan1.0
WFIKKN1
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v218869,496 - 874,370 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1164,653,362 - 4,658,288 (+)NCBINHGRI_mPanPan1
PanPan1.116643,764 - 647,044 (+)NCBIpanpan1.1PanPan1.1panPan2
WFIKKN1
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1639,934,105 - 39,937,666 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl639,934,068 - 39,936,628 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha641,197,722 - 41,201,278 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0640,276,276 - 40,279,832 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl640,276,277 - 40,278,783 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1639,964,800 - 39,968,355 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0639,924,986 - 39,928,542 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0640,404,167 - 40,407,723 (-)NCBIUU_Cfam_GSD_1.0
Wfikkn1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024409344112,273,468 - 112,277,650 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936501371,384 - 373,859 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_004936501371,328 - 375,271 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
WFIKKN1
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl341,136,202 - 41,138,785 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1341,136,200 - 41,139,986 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
WFIKKN1
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.15547,499 - 554,080 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl5547,795 - 554,019 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366606830,584,546 - 30,588,856 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Wfikkn1
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046249131,443,399 - 1,448,669 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046249131,442,351 - 1,446,249 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in WFIKKN1
36 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3 copy number gain See cases [RCV000052367] Chr16:23141..11296695 [GRCh38]
Chr16:73141..11390552 [GRCh37]
Chr16:13141..11298053 [NCBI36]
Chr16:16p13.3-13.13		 pathogenic
GRCh38/hg38 16p13.3(chr16:29941-2560460)x3 copy number gain See cases [RCV000052368] Chr16:29941..2560460 [GRCh38]
Chr16:79941..2610461 [GRCh37]
Chr16:19941..2550462 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:46566-1800860)x3 copy number gain See cases [RCV000052369] Chr16:46566..1800860 [GRCh38]
Chr16:96566..1850861 [GRCh37]
Chr16:36566..1790862 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:46766-3214623)x3 copy number gain See cases [RCV000052370] Chr16:46766..3214623 [GRCh38]
Chr16:96766..3264623 [GRCh37]
Chr16:36766..3204624 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:23141-1773349)x1 copy number loss See cases [RCV000053251] Chr16:23141..1773349 [GRCh38]
Chr16:73141..1823350 [GRCh37]
Chr16:13141..1763351 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:23141-1712523)x1 copy number loss See cases [RCV000053252] Chr16:23141..1712523 [GRCh38]
Chr16:73141..1762524 [GRCh37]
Chr16:13141..1702525 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:46766-1997582)x1 copy number loss See cases [RCV000053253] Chr16:46766..1997582 [GRCh38]
Chr16:96766..2047583 [GRCh37]
Chr16:36766..1987584 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:105429-1499893)x1 copy number loss See cases [RCV000053267] Chr16:105429..1499893 [GRCh38]
Chr16:155427..1549894 [GRCh37]
Chr16:95427..1489895 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3 copy number gain See cases [RCV000133780] Chr16:46766..11525516 [GRCh38]
Chr16:96766..11619372 [GRCh37]
Chr16:36766..11526873 [NCBI36]
Chr16:16p13.3-13.13		 pathogenic
GRCh38/hg38 16p13.3(chr16:46766-1544014)x1 copy number loss See cases [RCV000134917] Chr16:46766..1544014 [GRCh38]
Chr16:96766..1594015 [GRCh37]
Chr16:36766..1534016 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:551385-722554)x3 copy number gain See cases [RCV000135264] Chr16:551385..722554 [GRCh38]
Chr16:601385..772554 [GRCh37]
Chr16:541386..712555 [NCBI36]
Chr16:16p13.3		 likely benign
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3 copy number gain See cases [RCV000136687] Chr16:46766..4247185 [GRCh38]
Chr16:96766..4297186 [GRCh37]
Chr16:36766..4237187 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:46722-1867327)x1 copy number loss See cases [RCV000137826] Chr16:46722..1867327 [GRCh38]
Chr16:96722..1917328 [GRCh37]
Chr16:36722..1857329 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh38/hg38 16p13.3(chr16:46766-882211)x1 copy number loss See cases [RCV000137979] Chr16:46766..882211 [GRCh38]
Chr16:96766..932211 [GRCh37]
Chr16:36766..872212 [NCBI36]
Chr16:16p13.3		 pathogenic|uncertain significance
GRCh38/hg38 16p13.3(chr16:412341-925326)x3 copy number gain See cases [RCV000139354] Chr16:412341..925326 [GRCh38]
Chr16:462341..975326 [GRCh37]
Chr16:402342..915327 [NCBI36]
Chr16:16p13.3		 uncertain significance
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3 copy number gain See cases [RCV000139166] Chr16:43732..13326806 [GRCh38]
Chr16:93732..13420663 [GRCh37]
Chr16:33732..13328164 [NCBI36]
Chr16:16p13.3-13.12		 pathogenic
GRCh38/hg38 16p13.3(chr16:534395-722554)x3 copy number gain See cases [RCV000140349] Chr16:534395..722554 [GRCh38]
Chr16:584395..772554 [GRCh37]
Chr16:524396..712555 [NCBI36]
Chr16:16p13.3		 benign
GRCh38/hg38 16p13.3(chr16:59980-1221651)x1 copy number loss See cases [RCV000141384] Chr16:59980..1221651 [GRCh38]
Chr16:109978..1271651 [GRCh37]
Chr16:49978..1211652 [NCBI36]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:450686-1007236)x3 copy number gain See cases [RCV000239842] Chr16:450686..1007236 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 copy number gain See cases [RCV000203445] Chr16:102839..28327676 [GRCh37]
Chr16:16p13.3-11.2		 pathogenic
GRCh37/hg19 16p13.3(chr16:97494-1257060)x3 copy number gain Breast ductal adenocarcinoma [RCV000207237] Chr16:97494..1257060 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:324072-705832)x3 copy number gain Breast ductal adenocarcinoma [RCV000207302] Chr16:324072..705832 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:88165-1715454)x1 copy number loss See cases [RCV000239415] Chr16:88165..1715454 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:72769-1511716)x1 copy number loss See cases [RCV000240294] Chr16:72769..1511716 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:239130-841725)x3 copy number gain See cases [RCV000240506] Chr16:239130..841725 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-754083)x1 copy number loss See cases [RCV000446474] Chr16:85880..754083 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 copy number gain See cases [RCV000446684] Chr16:69193..90274381 [GRCh37]
Chr16:16p13.3-q24.3		 pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448) copy number gain See cases [RCV000446555] Chr16:78801..9169448 [GRCh37]
Chr16:16p13.3-13.2		 pathogenic
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3 copy number gain See cases [RCV000445663] Chr16:97133..5122974 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:106859-735154)x3 copy number gain See cases [RCV000511218] Chr16:106859..735154 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:643377-3125125)x3 copy number gain See cases [RCV000510815] Chr16:643377..3125125 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 copy number gain See cases [RCV000511360] Chr16:85880..22442007 [GRCh37]
Chr16:16p13.3-12.2		 pathogenic
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3 copy number gain See cases [RCV000512194] Chr16:85880..19806921 [GRCh37]
Chr16:16p13.3-12.3		 pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 copy number gain See cases [RCV000512138] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3		 pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3 copy number gain See cases [RCV000510698] Chr16:85880..9883129 [GRCh37]
Chr16:16p13.3-13.2		 pathogenic
NM_053284.3(WFIKKN1):c.107A>G (p.Gln36Arg) single nucleotide variant Inborn genetic diseases [RCV003280175] Chr16:631360 [GRCh38]
Chr16:681360 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) copy number gain See cases [RCV000511296] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3		 pathogenic
NM_053284.3(WFIKKN1):c.130G>A (p.Asp44Asn) single nucleotide variant Inborn genetic diseases [RCV003266283] Chr16:631383 [GRCh38]
Chr16:681383 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-1498731)x1 copy number loss not provided [RCV000683740] Chr16:85880..1498731 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-3216551)x3 copy number gain not provided [RCV000683742] Chr16:85880..3216551 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1875694)x1 copy number loss not provided [RCV000683741] Chr16:85880..1875694 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3 copy number gain not provided [RCV000683743] Chr16:85880..11209288 [GRCh37]
Chr16:16p13.3-13.13		 pathogenic
NC_000016.10:g.(?_582883)_(648190_?)del deletion Epilepsy [RCV000708134] Chr16:582883..648190 [GRCh38]
Chr16:632883..698190 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 copy number gain not provided [RCV000738918] Chr16:88165..90274695 [GRCh37]
Chr16:16p13.3-q24.3		 pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 copy number gain not provided [RCV000738915] Chr16:61451..90294632 [GRCh37]
Chr16:16p13.3-q24.3		 pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 copy number gain not provided [RCV000738917] Chr16:88165..90163275 [GRCh37]
Chr16:16p13.3-q24.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:591586-784800)x3 copy number gain not provided [RCV000738948] Chr16:591586..784800 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:593277-685708)x3 copy number gain not provided [RCV000738951] Chr16:593277..685708 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:610419-776308)x1 copy number loss not provided [RCV000738955] Chr16:610419..776308 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:624108-780942)x3 copy number gain not provided [RCV000738956] Chr16:624108..780942 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:624108-784800)x3 copy number gain not provided [RCV000738957] Chr16:624108..784800 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:682670-685708)x4 copy number gain not provided [RCV000738958] Chr16:682670..685708 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:682670-784800)x3 copy number gain not provided [RCV000738959] Chr16:682670..784800 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:683959-781623)x3 copy number gain not provided [RCV000738960] Chr16:683959..781623 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:683959-784800)x3 copy number gain not provided [RCV000738961] Chr16:683959..784800 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:569754-781623)x3 copy number gain not provided [RCV000751474] Chr16:569754..781623 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:569754-847743)x3 copy number gain not provided [RCV000751475] Chr16:569754..847743 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:570466-781623)x3 copy number gain not provided [RCV000751476] Chr16:570466..781623 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:575312-700644)x3 copy number gain not provided [RCV000751478] Chr16:575312..700644 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:580124-875402)x1 copy number loss not provided [RCV000751479] Chr16:580124..875402 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:61451-1593645)x1 copy number loss not provided [RCV000751445] Chr16:61451..1593645 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:450309-951598)x3 copy number gain not provided [RCV000751466] Chr16:450309..951598 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:569754-700644)x4 copy number gain not provided [RCV000751472] Chr16:569754..700644 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:569754-747013)x3 copy number gain not provided [RCV000751473] Chr16:569754..747013 [GRCh37]
Chr16:16p13.3		 benign
GRCh37/hg19 16p13.3(chr16:109978-4316797) copy number gain Chromosome 16p13.3 duplication syndrome [RCV000767731] Chr16:109978..4316797 [GRCh37]
Chr16:16p13.3		 pathogenic
NM_053284.3(WFIKKN1):c.1564G>A (p.Ala522Thr) single nucleotide variant Inborn genetic diseases [RCV003267189] Chr16:633974 [GRCh38]
Chr16:683974 [GRCh37]
Chr16:16p13.3		 uncertain significance
NC_000016.9:g.(?_624055)_(2115656_?)del deletion Tuberous sclerosis 2 [RCV000811345] Chr16:624055..2115656 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-830613)x1 copy number loss not provided [RCV000846660] Chr16:85880..830613 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-2053328)x1 copy number loss not provided [RCV000849039] Chr16:85880..2053328 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1468459)x1 copy number loss not provided [RCV000848130] Chr16:85880..1468459 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1166355)x1 copy number loss not provided [RCV001006741] Chr16:85880..1166355 [GRCh37]
Chr16:16p13.3		 pathogenic
NC_000016.9:g.(?_624055)_(2550979_?)dup duplication Idiopathic generalized epilepsy [RCV001033790] Chr16:624055..2550979 [GRCh37]
Chr16:16p13.3		 uncertain significance
NC_000016.9:g.(?_624055)_(2148005_?)del deletion Tuberous sclerosis 2 [RCV001033183] Chr16:624055..2148005 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3 copy number gain not provided [RCV001537890] Chr16:84485..5251013 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:364182-1186480)x3 copy number gain not provided [RCV001006744] Chr16:364182..1186480 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:106988-735154)x3 copy number gain not provided [RCV001006742] Chr16:106988..735154 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3 copy number gain not provided [RCV001259749] Chr16:85880..5249457 [GRCh37]
Chr16:16p13.3		 pathogenic
NC_000016.9:g.(?_624055)_(2153916_?)dup duplication Epilepsy [RCV001344085]|Idiopathic generalized epilepsy [RCV001316565] Chr16:624055..2153916 [GRCh37]
Chr16:16p13.3		 uncertain significance
NC_000016.9:g.(?_632883)_(698190_?)del deletion Epilepsy [RCV001314118] Chr16:632883..698190 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:85880-754083) copy number loss not specified [RCV002052499] Chr16:85880..754083 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85880-1468828) copy number loss not specified [RCV002052500] Chr16:85880..1468828 [GRCh37]
Chr16:16p13.3		 pathogenic
NC_000016.9:g.(?_256302)_(5971108_?)dup duplication Familial Mediterranean fever [RCV001877532]|Fanconi anemia [RCV001877533]|not provided [RCV001877531] Chr16:256302..5971108 [GRCh37]
Chr16:16p13.3		 uncertain significance
NC_000016.9:g.(?_256302)_(4852572_?)dup duplication Epilepsy [RCV003113403]|Idiopathic generalized epilepsy [RCV003109446]|Saldino-Mainzer syndrome [RCV003113404] Chr16:256302..4852572 [GRCh37]
Chr16:16p13.3		 uncertain significance
NC_000016.9:g.(?_256302)_(1843653_?)del deletion Idiopathic generalized epilepsy [RCV003109815] Chr16:256302..1843653 [GRCh37]
Chr16:16p13.3		 uncertain significance
NC_000016.9:g.(?_256302)_(1657267_?)del deletion Saldino-Mainzer syndrome [RCV003116765]|not provided [RCV003116766] Chr16:256302..1657267 [GRCh37]
Chr16:16p13.3		 pathogenic|no classifications from unflagged records
NC_000016.9:g.(?_256302)_(1918176_?)del deletion not provided [RCV003119703] Chr16:256302..1918176 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:111043-6627459)x3 copy number gain See cases [RCV002292215] Chr16:111043..6627459 [GRCh37]
Chr16:16p13.3		 pathogenic
GRCh37/hg19 16p13.3(chr16:85881-1350186)x1 copy number loss not provided [RCV002474576] Chr16:85881..1350186 [GRCh37]
Chr16:16p13.3		 pathogenic
NM_053284.3(WFIKKN1):c.1523G>A (p.Arg508His) single nucleotide variant Inborn genetic diseases [RCV002905072] Chr16:633933 [GRCh38]
Chr16:683933 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.966G>T (p.Gln322His) single nucleotide variant Inborn genetic diseases [RCV002774094] Chr16:633376 [GRCh38]
Chr16:683376 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1404G>T (p.Met468Ile) single nucleotide variant Inborn genetic diseases [RCV002686530] Chr16:633814 [GRCh38]
Chr16:683814 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1106G>C (p.Arg369Pro) single nucleotide variant Inborn genetic diseases [RCV002882386] Chr16:633516 [GRCh38]
Chr16:683516 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.622G>A (p.Asp208Asn) single nucleotide variant Inborn genetic diseases [RCV002774677] Chr16:633032 [GRCh38]
Chr16:683032 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.7G>A (p.Ala3Thr) single nucleotide variant Inborn genetic diseases [RCV002728812] Chr16:631260 [GRCh38]
Chr16:681260 [GRCh37]
Chr16:16p13.3		 likely benign
NM_053284.3(WFIKKN1):c.1016G>A (p.Arg339His) single nucleotide variant Inborn genetic diseases [RCV002771852] Chr16:633426 [GRCh38]
Chr16:683426 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1522C>T (p.Arg508Cys) single nucleotide variant Inborn genetic diseases [RCV002689428] Chr16:633932 [GRCh38]
Chr16:683932 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.516G>C (p.Glu172Asp) single nucleotide variant Inborn genetic diseases [RCV002691654] Chr16:632926 [GRCh38]
Chr16:682926 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1267C>T (p.Arg423Trp) single nucleotide variant Inborn genetic diseases [RCV002823334] Chr16:633677 [GRCh38]
Chr16:683677 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.154G>C (p.Glu52Gln) single nucleotide variant Inborn genetic diseases [RCV002950817] Chr16:631407 [GRCh38]
Chr16:681407 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1295G>A (p.Arg432His) single nucleotide variant Inborn genetic diseases [RCV002822318] Chr16:633705 [GRCh38]
Chr16:683705 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.245G>T (p.Gly82Val) single nucleotide variant Inborn genetic diseases [RCV002830966] Chr16:632655 [GRCh38]
Chr16:682655 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.914C>T (p.Ala305Val) single nucleotide variant Inborn genetic diseases [RCV002699126] Chr16:633324 [GRCh38]
Chr16:683324 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.491C>T (p.Pro164Leu) single nucleotide variant Inborn genetic diseases [RCV002788773] Chr16:632901 [GRCh38]
Chr16:682901 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1237C>G (p.Arg413Gly) single nucleotide variant Inborn genetic diseases [RCV002872876] Chr16:633647 [GRCh38]
Chr16:683647 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.244G>A (p.Gly82Ser) single nucleotide variant Inborn genetic diseases [RCV002931355] Chr16:632654 [GRCh38]
Chr16:682654 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.995G>A (p.Arg332His) single nucleotide variant Inborn genetic diseases [RCV002812589] Chr16:633405 [GRCh38]
Chr16:683405 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1579C>T (p.Arg527Cys) single nucleotide variant Inborn genetic diseases [RCV002900725] Chr16:633989 [GRCh38]
Chr16:683989 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1262G>A (p.Arg421His) single nucleotide variant Inborn genetic diseases [RCV002769487] Chr16:633672 [GRCh38]
Chr16:683672 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1036G>A (p.Ala346Thr) single nucleotide variant Inborn genetic diseases [RCV002672982] Chr16:633446 [GRCh38]
Chr16:683446 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1187G>A (p.Gly396Asp) single nucleotide variant Inborn genetic diseases [RCV002812939] Chr16:633597 [GRCh38]
Chr16:683597 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.503C>T (p.Pro168Leu) single nucleotide variant Inborn genetic diseases [RCV002674303] Chr16:632913 [GRCh38]
Chr16:682913 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1416C>G (p.Phe472Leu) single nucleotide variant Inborn genetic diseases [RCV003278566] Chr16:633826 [GRCh38]
Chr16:683826 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1318C>T (p.Arg440Trp) single nucleotide variant Inborn genetic diseases [RCV003208591] Chr16:633728 [GRCh38]
Chr16:683728 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.328G>A (p.Gly110Arg) single nucleotide variant Inborn genetic diseases [RCV003173627] Chr16:632738 [GRCh38]
Chr16:682738 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1561C>G (p.Arg521Gly) single nucleotide variant Inborn genetic diseases [RCV003186607] Chr16:633971 [GRCh38]
Chr16:683971 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.235C>T (p.Arg79Cys) single nucleotide variant Inborn genetic diseases [RCV003261324] Chr16:632645 [GRCh38]
Chr16:682645 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1357G>A (p.Gly453Ser) single nucleotide variant Inborn genetic diseases [RCV003265744] Chr16:633767 [GRCh38]
Chr16:683767 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.263C>T (p.Thr88Met) single nucleotide variant Inborn genetic diseases [RCV003338304] Chr16:632673 [GRCh38]
Chr16:682673 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.429C>G (p.Ala143=) single nucleotide variant not provided [RCV003395123] Chr16:632839 [GRCh38]
Chr16:682839 [GRCh37]
Chr16:16p13.3		 likely benign
NM_053284.3(WFIKKN1):c.460A>C (p.Ile154Leu) single nucleotide variant Inborn genetic diseases [RCV003384754] Chr16:632870 [GRCh38]
Chr16:682870 [GRCh37]
Chr16:16p13.3		 uncertain significance
NM_053284.3(WFIKKN1):c.1090G>C (p.Val364Leu) single nucleotide variant Inborn genetic diseases [RCV003375789] Chr16:633500 [GRCh38]
Chr16:683500 [GRCh37]
Chr16:16p13.3		 uncertain significance
GRCh37/hg19 16p13.3(chr16:85881-1657611)x1 copy number loss not provided [RCV003483253] Chr16:85881..1657611 [GRCh37]
Chr16:16p13.3		 pathogenic
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:848
Count of miRNA genes:599
Interacting mature miRNAs:674
Transcripts:ENST00000319070, ENST00000573440
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
SHGC-60694  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3716679,114 - 679,241UniSTSGRCh37
Build 3616619,115 - 619,242RGDNCBI36
Celera16879,248 - 879,375RGD
Cytogenetic Map16p13.3UniSTS
HuRef16600,413 - 600,540UniSTS
GeneMap99-GB4 RH Map1623.39UniSTS
Whitehead-RH Map162.1UniSTS
A009L31  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3716679,123 - 679,253UniSTSGRCh37
Build 3616619,124 - 619,254RGDNCBI36
Celera16879,257 - 879,387RGD
Cytogenetic Map16p13.3UniSTS
HuRef16600,422 - 600,552UniSTS
GeneMap99-GB4 RH Map1621.96UniSTS
RH41911  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3716684,433 - 684,608UniSTSGRCh37
Build 3616624,434 - 624,609RGDNCBI36
Celera16884,567 - 884,742RGD
Cytogenetic Map16p13.3UniSTS
HuRef16605,696 - 605,871UniSTS
GeneMap99-GB4 RH Map1622.88UniSTS
G32656  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh3716679,123 - 679,253UniSTSGRCh37
Celera16879,257 - 879,387UniSTS
Cytogenetic Map16p13.3UniSTS
HuRef16600,422 - 600,552UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 2 1 116 1 3 1 101 11 493 4 66 62 46
Low 1782 1670 1259 473 1044 324 3312 1222 3112 294 1268 1358 158 670 2263 3
Below cutoff 642 1303 341 142 762 133 924 954 102 116 111 182 12 532 478 1

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000319070   ⟹   ENSP00000324763
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl16630,985 - 634,117 (+)Ensembl
RefSeq Acc Id: ENST00000573440
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl16629,239 - 634,116 (+)Ensembl
RefSeq Acc Id: NM_053284   ⟹   NP_444514
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh3816630,985 - 634,117 (+)NCBI
GRCh3716681,012 - 684,116 (+)RGD
Build 3616621,013 - 624,117 (+)NCBI Archive
Celera16881,146 - 884,250 (+)RGD
HuRef16602,311 - 605,379 (+)ENTREZGENE
CHM1_116680,850 - 683,953 (+)NCBI
T2T-CHM13v2.016635,019 - 638,150 (+)NCBI
Sequence:
Reference Protein Sequences
RefSeq Acc Id: NP_444514   ⟸   NM_053284
- Peptide Label: precursor
- UniProtKB: Q8NBQ1 (UniProtKB/Swiss-Prot),   Q7LDW0 (UniProtKB/Swiss-Prot),   Q96S20 (UniProtKB/Swiss-Prot),   Q96NZ8 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: ENSP00000324763   ⟸   ENST00000319070
Protein Domains
BPTI/Kunitz inhibitor   Ig-like C2-type   Kazal-like   NTR   WAP

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q96NZ8-F1-model_v2 AlphaFold Q96NZ8 1-548 view protein structure

Promoters
RGD ID:6793606
Promoter ID:HG_KWN:22626
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   HeLa_S3,   K562,   Lymphoblastoid,   NB4
Transcripts:ENST00000319070,   UC002CHS.1
Position:
Human AssemblyChrPosition (strand)Source
Build 3616618,626 - 623,887 (+)MPROMDB
RGD ID:7230805
Promoter ID:EPDNEW_H21148
Type:initiation region
Name:WFIKKN1_1
Description:WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domaincontaining 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh3816630,985 - 631,045EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:30912 AgrOrtholog
COSMIC WFIKKN1 COSMIC
Ensembl Genes ENSG00000127578 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000319070 ENTREZGENE
  ENST00000319070.3 UniProtKB/Swiss-Prot
Gene3D-CATH 2.40.50.120 UniProtKB/Swiss-Prot
  2.60.40.10 UniProtKB/Swiss-Prot
  3.30.60.30 UniProtKB/Swiss-Prot
  4.10.410.10 UniProtKB/Swiss-Prot
  4.10.75.10 UniProtKB/Swiss-Prot
GTEx ENSG00000127578 GTEx
HGNC ID HGNC:30912 ENTREZGENE
Human Proteome Map WFIKKN1 Human Proteome Map
InterPro Elafin-like_sf UniProtKB/Swiss-Prot
  Ig-like_dom UniProtKB/Swiss-Prot
  Ig-like_dom_sf UniProtKB/Swiss-Prot
  Ig-like_fold UniProtKB/Swiss-Prot
  Ig_sub UniProtKB/Swiss-Prot
  Ig_sub2 UniProtKB/Swiss-Prot
  Kazal_dom UniProtKB/Swiss-Prot
  Kazal_dom_sf UniProtKB/Swiss-Prot
  Kunitz_BPTI UniProtKB/Swiss-Prot
  Kunitz_BPTI_sf UniProtKB/Swiss-Prot
  Netrin_domain UniProtKB/Swiss-Prot
  Prtase_inh_Kunz-CS UniProtKB/Swiss-Prot
  TIMP-like_OB-fold UniProtKB/Swiss-Prot
  WAP_dom UniProtKB/Swiss-Prot
  WFIKKN1 UniProtKB/Swiss-Prot
KEGG Report hsa:117166 UniProtKB/Swiss-Prot
NCBI Gene 117166 ENTREZGENE
OMIM 608021 OMIM
PANTHER ACP24A4-RELATED UniProtKB/Swiss-Prot
  PTHR45938:SF6 UniProtKB/Swiss-Prot
Pfam Ig_3 UniProtKB/Swiss-Prot
  Kunitz_BPTI UniProtKB/Swiss-Prot
  WAP UniProtKB/Swiss-Prot
PharmGKB PA134897686 PharmGKB
PRINTS BASICPTASE UniProtKB/Swiss-Prot
PROSITE BPTI_KUNITZ_1 UniProtKB/Swiss-Prot
  BPTI_KUNITZ_2 UniProtKB/Swiss-Prot
  IG_LIKE UniProtKB/Swiss-Prot
  KAZAL_2 UniProtKB/Swiss-Prot
  NTR UniProtKB/Swiss-Prot
  WAP UniProtKB/Swiss-Prot
SMART IGc2 UniProtKB/Swiss-Prot
  SM00131 UniProtKB/Swiss-Prot
  SM00409 UniProtKB/Swiss-Prot
  WAP UniProtKB/Swiss-Prot
Superfamily-SCOP SSF100895 UniProtKB/Swiss-Prot
  SSF48726 UniProtKB/Swiss-Prot
  SSF50242 UniProtKB/Swiss-Prot
  SSF57256 UniProtKB/Swiss-Prot
  SSF57362 UniProtKB/Swiss-Prot
UniProt Q7LDW0 ENTREZGENE
  Q8NBQ1 ENTREZGENE
  Q96NZ8 ENTREZGENE
  Q96S20 ENTREZGENE
  WFKN1_HUMAN UniProtKB/Swiss-Prot
UniProt Secondary Q7LDW0 UniProtKB/Swiss-Prot
  Q8NBQ1 UniProtKB/Swiss-Prot
  Q96S20 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-03-02 WFIKKN1  WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1  C16orf12  chromosome 16 open reading frame 12  Data merged from RGD:1351577 737654 PROVISIONAL